The business of affordable medicines
Dr. Jack Aurora is Ph.D. in pharmaceutical sciences with over 19 years of Quality and Compliance driven research and management experience to his credit. Dr. Aurora’s research experience is in all the dosage forms including but not limiting to solids, semi-solids, liqui…more ›
Frances graduated from Magdalen, Oxford, in Biochemistry and immediately joined Savory Milln as a UK pharmaceuticals analyst. Following its takeover by Swiss Bank Corporation, she took up a role in pan-European pharmaceuticals coverage at IMI before moving to Nomura in …more ›
Since November 2008 Michael Ewers is Managing Director/CEO of betapharm Arzneimittel GmbH in Augsburg, which is a subsidiary of the international pharmaceutical company Dr. Reddy's Laboratories, headquartered in Hyderabad, India. Ewers started his professional caree…more ›
Dominic is a Vice Chairman of Rothschild in London and also holds the position of Global Head of Healthcare. He has been at Rothschild since 1998. As an experienced M&A practitioner focused on the healthcare industry, he has a long track record of completed health…more ›
Work Experience Jun 2011 to Present Group Product Manager in Respiratory Department in ELPEN Pharmaceutical Co. Inc. Jul 2009 - Jun 2011 Senior Product Manager in Respiratory Department in ELPEN Pharmaceutical Co. Inc. Jan 2007 – Jul 2009 Product Manager in Respiratory…more ›
The largest European generic medicines strategy event
The World Generic Medicines Congress addresses the key market trends, pricing & competition pressures, opportunities & future environment for the generics sector. Come to Generic Medicines Europe to learn:
- Financial forecast and performance
- Sustainability of healthcare in Europe
- Market trends and opportunities
- Health economics and healthcare policy
- Legal issues and patent reform
- Globalisation strategy
- Biosimilar development
Hear from: Watson, Synthon, Pfizer, Dr Reddy’s, Towa Pharmaceuticals Japan, Hospira, European Commission and many more!
Sponsors
The focus for Generic Medicines Europe 2012
As usual we will be covering all the hot topics:
- How to become a successful generic player
- Global policy update
- IP developments
- Big Pharma and generics
- Challenges of launching a biosimilar
- International markets and dynamic
- Building scale market share and value
This conference bridges the gap between international generic manufacturers, pharma manufacturers, regulatory bodies, policy decision makers and financial organisations.
Who should attend
- Generic Pharmaceutical Manufacturers
- Pharmaceutical Manufacturers
- Investment Banks
- API Manufacturers
- Pharmaceutical Wholesalers
- Pharmaceutical Distributors
- Consultants
- Laws firms
Who should sponsor
- Contract Research Organisation
- Equipment Providers
- Consultants
- Venture Capitalists
- Law firms
There are limited sponsorship opportunities available
Generic Medicines USA 2012
Generic Medicines Europe is part of an international series of events. The Generic Medicines USA 2012 event will take place on the 13-16 November 2012 in Washington D.C.
Limited opportunities to speak at the conference exist for leading solution providers
